Ânima (ANIM3) Q2 2024 earnings summary

Executive summary

• Leadership transition to Paula Harraca as CEO, the first non-founding member, marking a new growth cycle focused on operational efficiency, governance, and value generation.

• Achieved robust financial growth in 2Q24, with significant margin expansion, improved profitability, and resilience after navigating pandemic challenges and major acquisitions.

• Emphasis on strengthening brand value, disciplined team, and sustainable growth in Core, Digital, and Inspirali medical education segments.

• Focus on operational efficiency, cost control, and cash generation remains a priority.

Financial highlights

• Net revenue grew 4.3% year-over-year in 1H24 to R$1,967.7 million, with a 12.1% increase in weighted ticket across segments.

• Adjusted EBITDA ex-IFRS16 reached R$595.9 million (30.3% margin) in 1H24, up 22.5% year-over-year, surpassing BRL 1 billion LTM.

• Net debt reduced to 2.76x EBITDA LTM ex-IFRS16, down from 3.91x a year ago, with net debt down by R$143.4 million in 1H24.

• Operating cash flow increased 29% year-over-year to R$727.5 million in 1H24; cash generation up 40.6% to R$450.4 million.

• Cash position sufficient to cover amortizations through 2027 and 4.5x above obligations due by year-end.

Outlook and guidance

• Focus on a new "top-line wave" to drive growth in ticket prices, value proposition, and operational efficiency, with disciplined CAPEX and deleveraging.

• Strategy includes granular brand, campus, and program-level initiatives, with expansion in digital and medical education segments.

• Continued discipline in cost management and efficiency gains expected to support margin growth and shareholder returns.